[Stroke MRI for risk assessment of intracerebral hemorrhage associated with thrombolytic therapy]
Standard
[Stroke MRI for risk assessment of intracerebral hemorrhage associated with thrombolytic therapy]. / Singer, O C; Fiehler, Jens; Berkefeld, J; Neumann-Haefelin, T.
in: NERVENARZT, Jahrgang 80, Nr. 2, 2, 2009, S. 130, 132-136.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Stroke MRI for risk assessment of intracerebral hemorrhage associated with thrombolytic therapy]
AU - Singer, O C
AU - Fiehler, Jens
AU - Berkefeld, J
AU - Neumann-Haefelin, T
PY - 2009
Y1 - 2009
N2 - This article summarizes recent developments concerning MRI-based risk assessment of symptomatic intracerebral hemorrhage (sICH) associated with thrombolytic therapy for acute stroke. Special attention is paid to three imaging parameters: cerebral microangiopathy, lesion size on diffusion weighted imaging (DWI), and the role of cerebral microbleeds. Both severe cerebral microangiopathy and increasing lesion size on DWI are now established risk factors for sICH following thrombolysis, while the presence of a single or few microbleeds is not associated with a substantially elevated sICH risk.
AB - This article summarizes recent developments concerning MRI-based risk assessment of symptomatic intracerebral hemorrhage (sICH) associated with thrombolytic therapy for acute stroke. Special attention is paid to three imaging parameters: cerebral microangiopathy, lesion size on diffusion weighted imaging (DWI), and the role of cerebral microbleeds. Both severe cerebral microangiopathy and increasing lesion size on DWI are now established risk factors for sICH following thrombolysis, while the presence of a single or few microbleeds is not associated with a substantially elevated sICH risk.
M3 - SCORING: Zeitschriftenaufsatz
VL - 80
SP - 130, 132-136
JO - NERVENARZT
JF - NERVENARZT
SN - 0028-2804
IS - 2
M1 - 2
ER -
